Domain-Like Receptor Signaling Nucleotide-Binding Oligomerization Their Requirement of TLR and Dendritic Cells but Show Redundancy in + Immunization Are Dependent on CD 11 c Replication-Defective Adenovirus Serotype 5 T Cell Responses following + CD 8 Spies and
暂无分享,去创建一个
Sudhir | Kylie M. Quinn | B. Pulendran | A. Iwasaki | J. Gall | R. Seder | Lisa M. Mattei | P. Darrah | U. Wille-Reece | R. Lindsay | P. Kasturi | A. Gregory
[1] M. Betts,et al. Corrigendum: Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells , 2009, Nature Medicine.
[2] A. Aderem,et al. Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. , 2009, Immunity.
[3] R. Koup,et al. Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. , 2009, The Journal of general virology.
[4] F. Ginhoux,et al. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells , 2008, Nature Reviews Immunology.
[5] E. Unanue,et al. Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity , 2008, Science.
[6] J. Villadangos,et al. Antigen-presentation properties of plasmacytoid dendritic cells. , 2008, Immunity.
[7] J. Connolly,et al. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I , 2008, Nature Immunology.
[8] M. Roederer,et al. T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.
[9] K. Mansfield,et al. Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys , 2008, Journal of Virology.
[10] J. Tschopp,et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response , 2008, Nature.
[11] B. Pulendran,et al. Division of labor, plasticity, and crosstalk between dendritic cell subsets. , 2008, Current opinion in immunology.
[12] H. de la Salle,et al. Antigen crosspresentation by human plasmacytoid dendritic cells. , 2007, Immunity.
[13] H. Mizuguchi,et al. Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. , 2007, Human gene therapy.
[14] R. Koup,et al. Myeloid and Plasmacytoid Dendritic Cells Are Susceptible to Recombinant Adenovirus Vectors and Stimulate Polyfunctional Memory T Cell Responses , 2007, The Journal of Immunology.
[15] Mario Roederer,et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.
[16] K. Mansfield,et al. Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D , 2007, Journal of Virology.
[17] G. Nabel,et al. Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells , 2007, PLoS pathogens.
[18] Xiaopei Huang,et al. Innate Immune Response to Adenoviral Vectors Is Mediated by both Toll-Like Receptor-Dependent and -Independent Pathways , 2007, Journal of Virology.
[19] A. Kiang,et al. Adenovirus Infection Triggers a Rapid, MyD88-Regulated Transcriptome Response Critical to Acute-Phase and Adaptive Immune Responses In Vivo , 2006, Journal of Virology.
[20] Meredith O'Keeffe,et al. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9‐dependent maturation and IFN‐α production , 2006, The journal of gene medicine.
[21] J. Bertin,et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. , 2006, Immunity.
[22] M. Lifton,et al. Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity , 2005, Journal of Virology.
[23] M. Bevan,et al. CD8α+ Dendritic Cells Selectively Present MHC Class I-Restricted Noncytolytic Viral and Intracellular Bacterial Antigens In Vivo1 , 2005, The Journal of Immunology.
[24] G. Trinchieri,et al. Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.
[25] S. Kostense,et al. Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1 , 2004, The Journal of Immunology.
[26] S. Kostense,et al. Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors , 2004, Journal of Virology.
[27] G. Belz,et al. Epidermal Viral Immunity Induced by CD8α+ Dendritic Cells But Not by Langerhans Cells , 2003, Science.
[28] R. K. Evans,et al. Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene , 2003, Journal of Virology.
[29] M. Gilliet,et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. , 2003, Blood.
[30] 邊見 弘明,et al. A Toll-like receptor recognizes bacterial DNA , 2003 .
[31] E. Shevach,et al. Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells , 2001, The Journal of Immunology.
[32] J. Wilson,et al. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] M. Bevan,et al. Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo , 2000, The Journal of experimental medicine.
[34] S. Akira,et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.
[35] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[36] M. Kay,et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors , 1997, Journal of virology.
[37] M. Tymms,et al. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] G. Trinchieri,et al. Recombinant IL–12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung , 1995, Nature Medicine.
[39] James M. Wilson,et al. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. , 1995, Journal of immunology.
[40] Z. Xiang,et al. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[41] H. Ertl,et al. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses , 1995, Journal of virology.
[42] H. Ertl,et al. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. , 1994, Immunity.